Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)

National Institutes of Health · United States government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

January 29, 2029
Response Due
Active
Status

Opportunity Overview

<p>The NIGMS Biomedical Technology Optimization and Dissemination Centers (BTOD) program supports optimization of late-stage technologies that have demonstrated laboratory feasibility. The centers will move the technologies to the point where they can be widely used and will promote their dissemination within the biomedical research community. NIGMS intends to reissue a Notice of Funding Opportunity to continue to support the BTOD Centers program.</p>

This is one of 1,276 active United States Health Services opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyNational Institutes of Health
CountryUnited States
CategoryHealth Services
NAICS93.859
PublishedJune 08, 2026
Procurement stageRequest for Proposal (RFP)
Response dueJanuary 29, 2029
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 09, 2026

Source: U.S. Government (Simpler.Grants.gov) — public domain. Not affiliated with or endorsed by the United States Government.

Related Opportunities in United States

Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)
NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)
NCI Community Oncology Research Program (NCORP) Academic Community Sites (UG1 Clinical Trials Not Allowed)
NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed)
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
NIH Director’s New Innovator Award (DP2 Clinical Trial Optional)
Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
Limited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P50 Clinical Trial Optional)

See every United States Health Services opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United States Health Services intelligence report in your inbox

A personalized report on United States Health Services opportunities, emailed in 5-10 minutes. One per month, no account needed.